Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
GPXhdMrnnfTDeWf0